These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16062032)
1. [The novelty in the treatment of heart failure]. Reingardiene D Medicina (Kaunas); 2005; 41(7):625-31. PubMed ID: 16062032 [TBL] [Abstract][Full Text] [Related]
2. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Cavusoglu Y Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021 [TBL] [Abstract][Full Text] [Related]
3. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure. Cleland JG; Nikitin N; McGowan J Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409 [TBL] [Abstract][Full Text] [Related]
4. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
5. Levosimendan: a review of its use in the management of acute decompensated heart failure. Innes CA; Wagstaff AJ Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085 [TBL] [Abstract][Full Text] [Related]
6. How to treat acute decompensated heart failure in the 'beta-blocker era'? Marcondes-Braga FG; Mangini S; Ayub-Ferreira SM; Bocchi EA; Bacal F Eur J Heart Fail; 2010 Aug; 12(8):893-4. PubMed ID: 20675672 [No Abstract] [Full Text] [Related]
7. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure. Kivikko M; Lehtonen L Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064 [TBL] [Abstract][Full Text] [Related]
8. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan. García González MJ; Domínguez Rodríguez A Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860 [TBL] [Abstract][Full Text] [Related]
12. [Levosimendan--an alternative to conventional inotropic treatment of patients with acute heart failure?]. Rasmussen T; Schmidt H Ugeskr Laeger; 2006 Jan; 168(3):261-5. PubMed ID: 16430807 [TBL] [Abstract][Full Text] [Related]
13. Levosimendan: a new option in acute cardiac failure. Holley AD; Ziegenfuss M Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641 [No Abstract] [Full Text] [Related]
14. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930 [TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril. Antila S; Eha J; Heinpalu M; Lehtonen L; Loogna I; Mesikepp A; Planken U; Sandell EP Eur J Clin Pharmacol; 1996; 49(6):451-8. PubMed ID: 8706769 [TBL] [Abstract][Full Text] [Related]
17. Levosimendan: a novel agent in heart failure. Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085 [TBL] [Abstract][Full Text] [Related]
18. Levosimendan use in several scenarios of acute heart failure. Tavares M; Andrade AC; Mebazaa A Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402 [TBL] [Abstract][Full Text] [Related]